It has not yet received FDA approval, so it is classified as a research compound
doi: 10.1007/s11033-020-05590-5 Summary Keywords antidepressant effects, Ashwagandha, depressive disorder, Rhodiola, supplements Citation Li X, Li X, Li Y, Liu Z, Cai Y, Yao Q, Zhao S and Yu Q (2026) Rhodiola rosea , Ginkgo biloba , and Ashwagandha as novel antidepressant supplements: converging monoaminergic, neurotrophic, anti-inflammatory, and brain health pathways in depressive disorders
T.LebofskyM.FarhoodA.et al (2015)
288 C5aR1 signaling was also found to be critical for pathological neutrophil recruitment during high-fat diet-induced vascular inflammation in murine models
Supports healthy heart and cardiovascular function